PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,288,000 | +36.4% | 501,050 | +2.4% | 0.93% | +49.3% |
Q2 2022 | $944,000 | -37.6% | 489,376 | -4.0% | 0.62% | -22.7% |
Q1 2022 | $1,514,000 | -31.3% | 509,828 | +3.8% | 0.80% | -26.1% |
Q4 2021 | $2,205,000 | -7.1% | 491,033 | +0.6% | 1.09% | -9.5% |
Q3 2021 | $2,373,000 | +174.0% | 488,309 | +284.5% | 1.20% | +171.5% |
Q2 2021 | $866,000 | – | 127,000 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
CM Management, LLC | 200,000 | $972,000 | 0.72% |
GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |